Loading
Ge Li founded WuXi AppTec in Shanghai in 2000 and built the contract research and manufacturing network that much of the world's cancer pipeline now depends on.
A Columbia-trained chemist who created China's first major CRO, then WuXi Biologics and (with Juno) JW Therapeutics; WuXi's discovery chemistry, toxicology and manufacturing services sit behind a large share of Western and Chinese oncology programmes, which is why the company became the focus of the US BIOSECURE Act.
Shares WuXi AppTec, JW Therapeutics and the tag china.
Shares JW Therapeutics and the tag china.